Benjamin H Kaffenberger is an expert in Dermatology at The Ohio State University Wexner Medical Center (United States). As of October 2026, ScienceLeadR ranks Benjamin H Kaffenberger in the top 1% of experts worldwide for Pyoderma, Skin Ulcer and Dermatitis. Benjamin H Kaffenberger has authored 356 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 1,368 (community average: 125). How the SLR is computed.

LeadR Profile

Benjamin H Kaffenberger The Ohio State University Wexner Medical Center United States
1 368 ScienceLeadR Reputation 1368
Network Map

Dermatology

Subspecialties: Pharmacy - Immunology - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2010 - 2026

Source: PubMed

The Ohio State University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 356

Citations

Citations: 3 982 1st author: 20 Last author: 183 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The use of over-the-counter aerosolized triamcinolone acetonide in the treatment of peristomal pyoderma gangrenosum: a case series.
PMID 42640996 — tissue adhesions, triamcinolone, ostomy, triamcinolone acetonide, administration, topical, therapeutics, pyoderma, steroids, pyoderma gangrenosum
Wounds20260
Pyoderma Gangrenosum Phenotype Classification.
PMID 42555014 — skin, comorbidity, phenotype, classification, skin diseases, surveys and questionnaires, research, dermatologists, pyoderma, pyoderma gangrenosum
JAMA Dermatol20260
High Level of Uncertainty in Assigning Causative Medications in Drug Reaction with Eosinophilia and Systemic Symptoms: A Retrospective Cohort Analysis.
PMID 42492633 — pharmaceutical preparations, drug hypersensitivity syndrome, uncertainty, signs and symptoms, dermatology, eosinophilia
J Am Acad Dermatol20260
Attendance at a Post-Discharge Dermatology Clinic Is Associated With Reduced Rehospitalization Risk for Primary Dermatologic Conditions.
PMID 42265835 — dermatology
Int J Dermatol20260
RAS pathway activation and microenvironmental adaptation as hallmarks of myeloid sarcoma.
PMID 42160138 — genes, ras, neoplasms, sarcoma, myeloid, sarcoma
Blood Cancer Discov20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 2 3
N/A 2

By status:

Completed 4
Withdrawn 1

By type:

Interventional 5

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map